Tenter A M, Johnson A M
Department of Microbiology and Infectious Diseases, Flinders University School of Medicine, Flinders Medical Centre, South Australia.
Parasitol Res. 1991;77(3):197-203. doi: 10.1007/BF00930858.
We developed an enzyme-linked immunosorbent assay (ELISA) that uses one of two recombinant polypeptides, termed H4/GST and H11/GST, as diagnostic antigens for the detection of antibodies to Toxoplasma gondii in human sera. A total of 59 sera from humans with acute toxoplasmosis, 194 sera from patients with chronic toxoplasmosis, and 151 sera from subjects who were not infected with T. gondii were examined. In all, 68% of the sera from humans with acute toxoplasmosis reacted positively with one or both recombinant T. gondii antigens. By contrast, only 14% of those from patients with chronic toxoplasmosis recognized H4/GST or H11/GST. None of the sera from humans who were not infected with T. gondii, including patients with echinococcosis, entamoebosis, toxocarosis, trichinellosis, glandular fever, or rheumatoid arthritis, recognized H4/GST or H11/GST.
我们开发了一种酶联免疫吸附测定(ELISA),该方法使用两种重组多肽之一,即H4/GST和H11/GST,作为诊断抗原,用于检测人血清中抗弓形虫抗体。共检测了59份急性弓形虫病患者的血清、194份慢性弓形虫病患者的血清以及151份未感染弓形虫的受试者的血清。总体而言,68%的急性弓形虫病患者血清与一种或两种重组弓形虫抗原呈阳性反应。相比之下,慢性弓形虫病患者中只有14%的人识别H4/GST或H11/GST。未感染弓形虫的人(包括患有棘球蚴病、内阿米巴病、弓蛔虫病、旋毛虫病、传染性单核细胞增多症或类风湿性关节炎的患者)的血清均未识别H4/GST或H11/GST。